IRCT20190122042450N4RecruitingPhase 3
Prevention of COVID-19 disease after contact with an infected patient with coronavirus after taking hydroxychloroquine in the community
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 1,000
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 40 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Clinical symptoms including: Fever
- •Shortness of breath
- •Positive Covide test
- •Typical symptoms on a CT scan
Exclusion Criteria
- •Hypersensitivity reaction to Hydroxychloroquine
- •Already taking Chloroquine or Hydroxychloroquine
- •Cardiac Arrhythmia
- •Already taking drugs that prolong QT
- •Decreased renal function in stages 4 and 5.(GFR <30)
- •The history of enzymatic disorders caused by some drugs that result in red blood cell lysis (G6PD).
- •The history of Retinopathy
Investigators
Similar Trials
Active, not recruiting
Phase 1
High dose Vitamin D in Preventing Aggravation of COVID-19SARS-COV-2 positive patientsMedDRA version: 23.0Level: LLTClassification code 10084382Term: Coronavirus disease 2019System Organ Class: 100000004862MedDRA version: 20.0Level: PTClassification code 10050713Term: Vitamin DSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.0Level: LLTClassification code 10013097Term: Disease aggravationSystem Organ Class: 100000004867EUCTR2020-001793-30-DKCopenhagen University Hospital of Bispebjerg480
Active, not recruiting
Phase 1
EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalSCOVID-19MedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862EUCTR2020-001385-11-ESPlan Nacional Sobre SIDA4,000
Active, not recruiting
Phase 2
COVID-19 Prevention of worsening of symptoms in asymptomatic to mild patients by combined use of kakkonto and hochuekkito:Exploratory open-label randomized controlled trialCOVID-19JPRN-jRCTs041200072Ogawa Keiko100
Not yet recruiting
Phase 3
Prevention and treatment for covid-19 associated severe pneumonia in The Gambia: a randomized clinical trial (PaTS-COVID) COVID-19PACTR202101544570971Medical Research Council Unit The Gambia at LSHTM1,200
Completed
Phase 3
Prevention of severe infectious complications after colorectal surgery using antimicrobial decontamination of the digestive tractwound infectionSurgical site infection1000401810017998NL-OMON47368niversitair Medisch Centrum Utrecht966